Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 15;8(4):237.
doi: 10.3390/pathogens8040237.

Identification of Candida Species from Clinical Samples in a Honduran Tertiary Hospital

Kathy Montes  1 , Bryan Ortiz  1 , Celeste Galindo  1   2 , Isis Figueroa  1 , Sharleen Braham  3 , Gustavo Fontecha  1
Affiliations

Identification of Candida Species from Clinical Samples in a Honduran Tertiary Hospital

Kathy Montes et al. Pathogens. .

Abstract

Candida species are one of the most important causes of human infections, especially in hospitals and among immunocompromised patients. The correct and rapid etiological identification of yeast infections is important to provide adequate therapy, reduce mortality, and control outbreaks. In this study, Candida species were identified in patients with suspected fungal infection, and phenotypic and genotypic identification methods were compared. A total of 167 axenic fungal cultures and 46 clinical samples were analyzed by HardyCHROM®, MicroScan®(Omron Microscan Systems Inc, Renton, WA, USA), and PCR-RFLP (Restriction Fragment Length Polymorphisms). The species of the C. albicans complex were the most frequent, followed by C. tropicalis and C. glabrata. Less common but clinically relevant species of Candida were also isolated. The comparison between the three methods was concordant, especially for the most common Candida species. Fungal DNA amplification was successful in all clinical samples.

Keywords: Candida spp.; HardyCHROM®; Honduras; MicroScan®; PCR-RFLP.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Frias-De-Leon M.G., Martinez-Herrera E., Acosta-Altamirano G., Arenas R., Rodriguez-Cerdeira C. Superficial candidosis by Candida duobushaemulonii: An emerging microorganism. Infect. Genet. Evol. 2019;75:103960. doi: 10.1016/j.meegid.2019.103960. - DOI - PubMed
    1. Santolaya M.E., Thompson L., Benadof D., Tapia C., Legarraga P., Cortes C., Rabello M., Valenzuela R., Rojas P., Rabagliati R., et al. A prospective, multi-center study of Candida bloodstream infections in Chile. PLoS ONE. 2019;14:e0212924. doi: 10.1371/journal.pone.0212924. - DOI - PMC - PubMed
    1. Yapar N. Epidemiology and risk factors for invasive candidiasis. Ther. Clin. Risk Manag. 2014;10:95–105. doi: 10.2147/TCRM.S40160. - DOI - PMC - PubMed
    1. Durga C.S., Gupta N., Soneja M., Bhatt M., Xess I., Jorwal P., Singh G., Ray A., Nischal N., Ranjan P., et al. Invasive fungal infections in critically ill patients: A prospective study from a tertiary care hospital in India. Drug. Discov. Ther. 2018;12:363–367. doi: 10.5582/ddt.2018.01068. - DOI - PubMed
    1. Montagna M.T., Lovero G., Borghi E., Amato G., Andreoni S., Campion L., Lo Cascio G., Lombardi G., Luzzaro F., Manso E., et al. Candidemia in intensive care unit: A nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013. Eur. Rev. Med. Pharmacol. Sci. 2014;18:661–674. - PubMed

LinkOut - more resources